Pfizer Clinical Research Unit (or PCRU) wanted to benefit from a solution that automatically generated an optimal plan for both sites. They sought to decrease planning time while making better use of their available capacity, in order to reduce the time-to-market for new drugs and vaccines. Thanks to this new planning system, Pfizer aims to generate reports and statistics more easily. In a second phase, they would also need to replace their operational planning system to benefit from a fully integrated tactical and operational planning system.
Product: APS | TRP | TEA | DWH | ARA | API | CDA | ADM | LDP